Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
TPF-DM is an enteral nutrition suspension specifically formulated for patients with diabetes, often used in clinical settings as a medical nutrition therapy adjunct. It is designed to provide controlled caloric and carbohydrate intake suitable for individuals with glucose metabolism disorders such as gestational diabetes mellitus (GDM). The product delivers 0.75 kcal/ml and is typically administered to help manage blood glucose levels while ensuring adequate nutritional support during periods when oral intake may be insufficient or needs precise regulation. In clinical trials, TPF-DM has been evaluated as part of combined therapy regimens to improve glycemic control and pregnancy outcomes in women with GDM[2][3][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on TPF-DM.